Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology [NA]

View source ↗

Summary

This is a clinical trial status update for an amyloid monoclonal antibody treatment in Parkinson disease patients with coexistent Alzheimer's pathology, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amyloid monoclonal antibody (investigational)

Snippet

Sponsor: Yonsei University | Conditions: Parkinson Disease | NA | Status: NOT_YET_RECRUITING